Literature DB >> 9589478

Non-Hodgkin's lymphoma presenting with adrenal insufficiency and hypothyroidism: an autopsy case report.

M Nasu1, M Aruga, J Itami, H Fujimoto, O Matsubara.   

Abstract

A 55-year-old male presented with an initial manifestation of primary adrenal insufficiency, hypothyroidism. Computed tomography scans showed enlarged bilateral adrenal glands and thyroid. A pathological diagnosis of diffuse large cell, B cell lymphoma was made by a needle biopsy of the adrenal gland. He was treated with combination chemotherapy and adrenal and thyroid hormone replacement. The lymphoma subsequently involved the central nervous system. He died of pneumonia 8 months after the presentation of the first symptom. The postmortem examination demonstrated a complete regression of lymphoma in the bilateral adrenal glands and thyroid. This is an extremely rare case of coexistent lymphoma of the adrenal glands and the thyroid presenting with adrenal failure and hypothyroidism.

Entities:  

Mesh:

Year:  1998        PMID: 9589478     DOI: 10.1111/j.1440-1827.1998.tb03883.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Primary Adrenal Lymphoma: Two Case Series From China.

Authors:  Jinyang Zeng; Fangfang Yan; Yulong Chen; Li Zang; Kang Chen; Zhaohui Lyu; Jingtao Dou; Yiming Mu; Mingzhu Lin; Guoqing Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-28       Impact factor: 5.555

2.  A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab-CHOP chemotherapy.

Authors:  Kyung Min Kim; Dok Hyun Yoon; Seung Geun Lee; Sung Nam Lim; Lyu Jin Sug; Jooryung Huh; Cheolwon Suh
Journal:  J Korean Med Sci       Date:  2009-06-16       Impact factor: 2.153

3.  Comparison of acquired cystic kidney disease between hemodialysis and continuous ambulatory peritoneal dialysis.

Authors:  J H Park; Y O Kim; J H Park; B S Kim; S A Yoon; C W Yang; Y S Kim; C H Han; B S Kim; B K Bang
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.